This track will explore the latest research and clinical practices in andrology, focusing on male reproductive health and associated disorders. Topics may include erectile dysfunction, male infertility, and hormonal therapies.

This session will address the cutting-edge approaches in the diagnosis, treatment, and management of bladder cancer. Emphasis will be placed on novel therapeutic strategies and the role of biomarkers in personalized medicine.

This track will discuss the latest insights into benign prostatic hyperplasia (BPH), including pathophysiology, diagnosis, and treatment options. Participants will gain knowledge on minimally invasive techniques and emerging therapies.

This session will highlight the importance of clinical trials in advancing urological care and research. Presentations will cover trial design, patient recruitment, and the impact of findings on clinical practice.

This track will focus on the latest techniques and technologies in endourology, including ureteroscopy and percutaneous nephrolithotomy. Discussions will include advancements in instrumentation and patient outcomes.

This session will address the unique challenges faced in female urology, including urinary incontinence and pelvic floor disorders. Experts will present innovative treatment options and multidisciplinary approaches.

This track will provide a comprehensive overview of kidney and urologic diseases, focusing on epidemiology, pathophysiology, and management strategies. Emphasis will be placed on chronic kidney disease and its complications.

This session will explore the field of pediatric urology, addressing congenital anomalies, urinary tract infections, and surgical interventions. Participants will discuss the latest research and best practices in managing urological conditions in children.

This track will delve into the complexities of prostate cancer, covering topics from early detection to advanced treatment options. Discussions will include the role of imaging, biomarkers, and individualized treatment plans.

This session will focus on the latest developments in renal cancer research and treatment, including targeted therapies and immunotherapy. Participants will explore the implications of recent clinical trials on practice.

This track will emphasize the importance of a multidisciplinary approach in the management of urological cancers. Experts will discuss collaboration among urologists, oncologists, and other healthcare professionals to optimize patient care.